| P2093 | author name string | Lei Jin | |
| | Divya Sai Katikaneni | |
| P2860 | cites work | STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling | Q24336398 |
| | SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling | Q24338194 |
| | MHC class II association with lipid rafts on the antigen presenting cell surface | Q27008954 |
| | Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins | Q28250176 |
| | Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC | Q28282150 |
| | The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules | Q28284349 |
| | Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY | Q28290621 |
| | Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future | Q28292558 |
| | B cell follicles and antigen encounters of the third kind | Q28296142 |
| | The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation | Q28586300 |
| | Crystal Structure of a Full-Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket | Q30395581 |
| | Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells | Q30489241 |
| | Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells | Q31095104 |
| | TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers. | Q32062094 |
| | 1D09C3, an mAb specific for MHC-II. | Q33316942 |
| | B cell development: signal transduction by antigen receptors and their surrogates. | Q33632426 |
| | Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways | Q33944243 |
| | Early events in B cell activation | Q34101385 |
| | Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses | Q34110588 |
| | Activated STING in a vascular and pulmonary syndrome | Q34241214 |
| | Distinct MHC Class II Molecules Are Associated on the Dendritic Cell Surface in Cholesterol-dependent Membrane Microdomains | Q34284990 |
| | The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor | Q34322410 |
| | Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid | Q34339243 |
| | Identification and characterization of a loss-of-function human MPYS variant | Q35022308 |
| | A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules | Q35556831 |
| | MHC class II signaling in antigen-presenting cells | Q35634046 |
| | STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells | Q35644477 |
| | TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. | Q35739705 |
| | B cell antigen receptor signaling 101. | Q35818846 |
| | In Vivo Pharmacodynamic Effects of Hu1D10 (Remitogen), a Humanized Antibody Reactive Against a Polymorphic Determinant of HLA-DR Expressed on B Cells | Q57373163 |
| | Phase II Trial of Remitogen™ (Humanized 1D10) Monoclonal Antibody Targeting Class II in Patients with Relapsed Low-Grade or Follicular Lymphoma | Q57376036 |
| | CD40 ligand-transduced co-stimulation of T cells in the development of helper function | Q58882277 |
| | Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes | Q59073132 |
| | The Actin and Tetraspanin Networks Organize Receptor Nanoclusters to Regulate B Cell Receptor-Mediated Signaling | Q63409208 |
| | Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma | Q68834769 |
| | Engagement of MHC class II molecules by staphylococcal superantigens activates src-type protein tyrosine kinases | Q71613579 |
| | A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes | Q73050432 |
| | HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes | Q73128519 |
| | Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22 | Q73163129 |
| | CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. | Q35962812 |
| | B Cell-Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus. | Q36031630 |
| | MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length | Q36061581 |
| | MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death | Q36713712 |
| | Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters | Q36832560 |
| | MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals | Q36845998 |
| | Pivotal advance: eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production | Q37327241 |
| | MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies | Q37397820 |
| | Visualizing the molecular and cellular events underlying the initiation of B-cell activation | Q37517325 |
| | SCIMP is a transmembrane non-TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages | Q37598447 |
| | NF-κB: roles and regulation in different CD4(+) T-cell subsets | Q38081166 |
| | Tetraspanins at a glance. | Q38240344 |
| | Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells | Q38788154 |
| | The tetraspanin web revisited by super-resolution microscopy | Q38852168 |
| | The tyrosine kinase Src promotes phosphorylation of the kinase TBK1 to facilitate type I interferon production after viral infection. | Q39042145 |
| | The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele | Q39121627 |
| | Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA. | Q39235226 |
| | Dynamics within tetraspanin pairs affect MHC class II expression | Q39402003 |
| | The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange | Q39809598 |
| | Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo | Q39822717 |
| | MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells | Q39835067 |
| | Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer | Q39983076 |
| | The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice | Q40321930 |
| | A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia | Q40375510 |
| | Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts | Q40659031 |
| | Lipid raft-dependent and -independent signaling through HLA-DR molecules | Q40681344 |
| | CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines | Q40975312 |
| | Signalling strength determines proapoptotic functions of STING. | Q41621190 |
| | Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure | Q41926622 |
| | Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD45. | Q42454385 |
| | Early biochemical events after MHC class II-mediated signaling on human B lymphocytes | Q42637623 |
| | MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme | Q44082619 |
| | MHC class II signaling function is regulated during maturation of plasmacytoid dendritic cells | Q44224972 |
| | Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions | Q44648165 |
| | Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study | Q44797709 |
| | Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer | Q44915586 |
| | Modeling of T cell contact-dependent B cell activation. IL-4 and antigen receptor ligation primes quiescent B cells to mobilize calcium in response to Ia cross-linking | Q44928750 |
| | Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes | Q44944046 |
| | MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes | Q46533260 |
| | Promotion of B cell immune responses via an alum-induced myeloid cell population | Q47323242 |
| | Reference values for B cell subpopulations from infancy to adulthood | Q51036853 |
| | Role of MHC class II on memory B cells in post-germinal center B cell homeostasis and memory response. | Q51985051 |
| | Clinical development of vascular disrupting agents: what lessons can we learn from ASA404? | Q52613053 |
| | The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes | Q57058779 |
| P433 | issue | 1 | |
| P304 | page(s) | 37-43 | |
| P577 | publication date | 2018-04-28 | |
| P1433 | published in | Human Immunology | Q15709955 |
| P1476 | title | B cell MHC class II signaling: A story of life and death | |
| P478 | volume | 80 | |